The decision to place the products on the FDA's official list for compounding doesn't come close to the standards for drug approval, but some worry that nuance will not be clear to the public, which may not be aware of the limited data for humans
FAK-paxillin pathway activation was strongest at higher local concentrations, supporting injection close to the tendon
Fourth, a number of patients withdrew from the study but no causal association can be determined
So essentially, more was being produced, but also, more was being excreted, resulting in an ongoing deficiency
Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment
These are not small risks